More bad news about anti-inflammatory agents.
Haller
Christine
C
University of California at San Francisco, SF, CA, USA.
D016907:Adverse Drug Reaction Reporting Systems; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D004335:Drug and Narcotic Control; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects; D007783:Lactones / Q000009:adverse effects*; D013449:Sulfonamides / Q000009:adverse effects; D013450:Sulfones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration; D000096926:Benzenesulfonamides
D000893:Anti-Inflammatory Agents; D052246:Cyclooxygenase 2 Inhibitors; D007555:Isoxazoles; D007783:Lactones; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; C406224:valdecoxib; D000096926:Benzenesulfonamides